Claire Scudder Selected Research

Therapeutics

1/2018

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire Scudder Research Topics

Disease

4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Hand-Foot Syndrome 11/2016
1	Hypertension (High Blood Pressure) 11/2016
1	Proteinuria 11/2016

Drug/Important Bio-Agent (IBA)

4	Capecitabine (Xeloda)FDA Link 01/2018 - 04/2014
1	Insulin (Novolin)FDA Link 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Angiogenesis InhibitorsIBA 11/2016
1	Bevacizumab (Avastin)FDA Link 11/2016
1	ProdrugsIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018
1	Adjuvant Chemotherapy 01/2018
1	Therapeutics 01/2018